Susceptibility Screening to bNAbs Teropavimab (GS-5423)
and Zinlirvimab (GS-2872)
in ART-Suppressed Participants
CROI 2023 Feb 20-23
Lisa Selzer, Laurie A. VanderVeen, Aiyappa Parvangada, Ross Martin, Sean E. Collins, Megha Mehrotra, Christian Callebaut
Gilead Sciences, Inc., Foster City, CA
